Progen Co., Ltd. Stock price

Equities

A296160

KR7296160005

Biotechnology & Medical Research

End-of-day quote Korea S.E. 23:00:00 22/02/2024 GMT 5-day change 1st Jan Change
7,400 KRW +1.09% Intraday chart for Progen Co., Ltd. -6.21% +3.50%
Dynamic Chart
1 day+1.09%
1 week-6.21%
Current month-8.64%
1 month-3.39%
3 months+89.02%
Current year+3.50%
More quotes
1 week
7 030.00
Extreme 7030
7 750.00
1 month
7 030.00
Extreme 7030
8 500.00
Current year
6 500.00
Extreme 6500
9 380.00
1 year
2 465.00
Extreme 2465
9 380.00
3 years
2 465.00
Extreme 2465
9 380.00
5 years
2 465.00
Extreme 2465
9 380.00
10 years
2 465.00
Extreme 2465
9 380.00
More quotes
Progen Co Ltd is a Korea-based company principally engaged in the researching and developing new drugs. The Company produces metabolic disease treatment drugs, immune disease treatment drugs, immune anticancer drugs, and others. The Company was established in 1998.
More about the company
  1. Stock
  2. Equities
  3. Stock Progen Co., Ltd. - Korea S.E.
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer